Economic impact of thermostable vaccines
نویسندگان
چکیده
منابع مشابه
Thermostable Newcastle Disease Vaccines
Robust vaccines are required to protect village chickens against Newcastle disease. Thermostable vaccines derived from avirulent Australian strains of Newcastle disease virus (strains V4 and I-2) have proved successful for this purpose. These vaccines have been developed through ACIAR projects and have been adopted by other international aid agencies. It is now possible to offer integrated work...
متن کاملOpportunities and challenges of developing thermostable vaccines.
All vaccines lose potency over time and the rate of potency loss is temperature-dependent. Therefore, cold-chain systems have been established to ensure that the potency of vaccines is maintained by storing them under refrigerated conditions (in most cases between 2 and 8 degrees C) until the point of use. This article aims to review the approaches being used to develop thermostable vaccine for...
متن کاملVaccines: specific features, simulation of impact and medico-economic modelling.
In a context where a number of vaccinations have recently been recommended in France, and where a large number of vaccines are under development, the Round Table has reviewed the specific features of vaccines in France, namely clinical development, medico-economic modelling, evaluation and communication. In each of these domains, the key stages and processes to be improved have been identified,...
متن کاملThermostable nuclease: a study of clinical impact.
bayberry treatment of cholera described in ancient Chinese medicine. We found that an extract derived from a simple and rapid extraction of bayberry fruits could repress V. cholerae virulence gene expression at low concentrations and inhibit V. cholerae growth at high concentrations. Intriguingly, this bayberry extract did not inhibit or kill many non-pathogenic bacteria tested, including Esche...
متن کاملPublic health and economic impact of seasonal influenza vaccination with quadrivalent influenza vaccines compared to trivalent influenza vaccines in Europe
Influenza B strains represent on average 23% of all circulating strains in Europe and when there is a vaccine mismatch on B strains, additional influenza-related hospitalizations and deaths as well as substantial additional costs are observed. The objective was to estimate the public health and economic impact of seasonal influenza vaccination with quadrivalent influenza vaccines (QIV) compared...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Vaccine
سال: 2017
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2017.03.081